Cancer Immunotherapy Generates Immense Interest
Cancer has been a threatening global concern for a long time. Estimates show that every year it swipes away around eight million lives. Immunotherapy, also known as Biotherapy, is one of the few treatments used to fight cancer. It either uses the body’s very own immune system to fight cancer cells or the immune system is boosted using proteins that are administered externally. This form of treatment was initiated in the late 1800s to treat cancer patients but little progress has been made due to the advent of radiation therapy, which seemed more promising at the time.
However, immunotherapy is coming back as a major offensive measure against all forms of cancer. It is a very promising form of treatment but, as it has been neglected due to more cosmetic forms of treatment, it requires a great deal of research and funding before we can start saving precious lives with this method. Immunotherapy for cancer has created a lot of interest in the medical sciences and makes a big promise to the people in need.
Due to immense interest in immunotherapy by research groups and financiers alike, need has given rise to the formation of its own stock index. This is where different groups can interact and raise much needed capital to make immunotherapy a success. Currently there are around 25 companies registered under the index worth around 100 million dollars. Whether it’s the need that is felt to fight cancer or just the hype created by the media, investors are pouring in to finance Loncar Cancer Immunotherapy.
One of the drawbacks of immunotherapy is its cost. Some of the new procedures are rather expensive and it would be a challenge to make them accessible to the general public except a handful of those who can afford it. Another factor is that there has been very limited research in this area and researchers know very few facts except that it is substantially effective for certain types of cancer over other forms of treatment. But due to its positive results, cancer immunotherapy has globally been able to generate massive interest.
How the Procedure Works
The body’s immune system instinctively fights against malicious external bodies such as virus, fungi and bacteria. Immunotherapy works in a very similar manner by inducing the body’s immune system to battle against cancerous cells and tissue. However, sometimes the immune system does not recognize the cancer as a harmful substance, which creates a problem.
To attend to this matter, monoclonal antibodies are introduced into the body that latch onto the proteins found on top of the cancer cells. This marks the cancer cells as harmful which can then be easily targeted by the immune system. Some monoclonal antibodies can also be used to carry the cancer drugs directly to the cancer cells. Through this process monoclonal antibodies can also be used to detect cancer cells.
There are three main types of immunotherapy: monoclonal antibodies, cancer vaccines, and non-specific immunotherapies. All of them have different variation of results for different types of cancer. Research for newer and better forms of immunotherapy is also underway and advancements are being made every day. This is what has caused an immense interest in the procedure, and it seems that immunotherapy might soon make a leap again into the world of cancer treatments.